tiprankstipranks
pc:orasi

Orasis Pharmaceuticals

Ponte Vedra Beach, Florida, US
https://www.orasis-pharma.com/
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company dedicated to advancing vision care through innovative solutions. The company is focused on the development and commercialization of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel eye drop designed to treat presbyopia in adults.

Leadership & Board

Current Number of Employees72
Current LinkedIn Followers7,832

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$78M
Total Amount Raised$78M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$78M
Latest Funding Amount$78M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Employee Trend

Orasis Pharmaceuticals had 72 employees as of April 27, 2026. The number of employees decreased by 2 (2.70%) week-over-week.
72Latest Employee Count
2(-2.70%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Orasis Pharmaceuticals had 7,832 followers as of April 27, 2026. The number of followers increased by 35 (0.45%) week-over-week.
7,832Latest Followers Count
35(0.45%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series D
$78.00M

Investors

Related News and Analysis